1.90Open1.90Pre Close3 Volume0 Open Interest2.50Strike Price495.00Turnover0.00%IV15.93%PremiumDec 20, 2024Expiry Date1.37Intrinsic Value100Multiplier19DDays to Expiry0.18Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.84Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Passage Bio Stock Discussion
NOTE:
1. Not all of these stocks will go up. Everything relies on market sentiment/buy pressure, the satanic shorts including dark pool.
2. The SI CTB and shorts availability are based on 11/29 data and may get updated Monday.
3. NEVER open position without momentum.
$Vision Marine Technologies (VMAR.US)$ News 12/1. Production Partnership for First Commercial Electric Pontoon Platform. Microfloat. C...
broke resistance
in again set stop loss
out at 1.01 nice profits for me
👀
📊⚡️📊
PHILADELPHIA, October 24, 2024 — Passage Bio, Inc. (Nasdaq: PASG), a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced the company delivered preclinical and interim clinical data as part of an oral presentation at the European Society of Gene & Cell Therapy (ESGCT) 31st Annual Congress being held October 22-25, 2024, in Rome, Italy.
Details of the oral presentation are below:
Abstract Title:...
No comment yet